Anzeige
Mehr »
Freitag, 13.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
258 Leser
Artikel bewerten:
(1)

Unique culture earns Oxford PharmaGenesis a Best Workplaces award

Oxford PharmaGenesis employees worldwide scored the leading HealthScience Communications consultancy highly for Trust, Values and Leadership Effectiveness in internationally renowned 2021 survey.

OXFORD, England, April 29, 2021 /PRNewswire/ -- Oxford PharmaGenesis has been recognized with an internationally renowned Best Workplaces award in the 2021 UK list published by Great Place to Work today.

The Great Place to Work survey received an 80% response rate from Oxford PharmaGenesis employees worldwide, with 91% of respondents saying "Taking everything into account, I would say this is a great place to work".

Oxford PharmaGenesis scored particularly highly for Trust, Values and Leadership Effectiveness.

"COVID-19 has affected employee welfare in organizations worldwide," said Chris Winchester, CEO of Oxford PharmaGenesis. "We as a company have gone out of our way to support our people through the pandemic as they juggle challenges at work and at home.

"In this dynamic, competitive environment, it's important not to lose sight of our people. We wanted to know how we were doing in our colleagues' eyes, and benchmark ourselves against peers to confirm that we are employer of choice in our sector.

"This accreditation reinforces our reputation as one of the most attractive, engaging and rewarding employers - not just in HealthScience Communications, but across all sectors in the UK and USA."

Sharon Frost, Global HR Director of Oxford PharmaGenesis said:

"This is a testament to our culture, strong values, strategic leadership and more. But it doesn't mean we can rest on laurels. We continue to listen to colleagues and focus on their development to ensure that this is a company of which we can all be proud."

Although Oxford PharmaGenesis did not enter the Great Place to Work awards in 2020, the firm experienced impressive growth, recruiting more than 100 new colleagues and opening a regional office in Melbourne, Australia. It also broadened its innovative capabilities and expertise through an enhanced informatics and data science practice.

About Oxford PharmaGenesis

Oxford PharmaGenesis is an award-winning, independent, global HealthScience consultancy providing communications services to the healthcare industry, professional societies and patient groups. Founded in 1998, Oxford PharmaGenesis a preferred supplier to 9 of the top 10 global pharmaceutical companies, and has more than 350 staff across offices in the UK, USA and Australia.

About Great Place to Work

Great Place to Work is the global authority on workplace culture. Since 1992, it has surveyed over 100 million employees globally and used those deep insights to define what element makes a great workplace: Trust. Great Place to Work UK helps organizations to quantify their culture and produce better business results by creating a high-trust work experience for all employees. Benchmark data collected by Great Place to Work is used to recognize Great Place to Work-Certified organizations and compile the acclaimed UK's Best Workplaces , UK's Best Workplaces for Women and UK's Best Workplaces in Tech lists. Everything it does is driven by the mission to build a better world by helping every organization become a truly 'great place to work'.

For more information, please contact: Ellie Challisellie.challis@pharmagenesis.com +44 1865 390144

© 2021 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.